8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2017 / Overview of systematic reviews and meta-analyses
An overview was conducted of 12 systematic reviews with meta-analyses of randomized controlled trials evaluating Ginkgo biloba extract (GbE) for dementia or cognitive impairment. Available evidence suggested potentially beneficial effects over placebo on cognitive performance, activities of daily living, and clinical global impression at doses greater than 200 mg/day (usually 240 mg/day) given for 22 weeks or longer, while appearing safe. Doses under 200 mg/day or durations under 22 weeks lacked sufficient evidence for clinically relevant effects. However, the quality of evidence in the included reviews ranged from low to moderate.
Yuan Q, Wang CW, Shi J, et al. J Ethnopharmacol, 2017. PMID 27940086
2017 / Systematic review of randomized controlled trials
This systematic review updated prior evidence and included 37 RCTs evaluating combined exercise training and dietary supplementation in adults aged 60 and older. Exercise increased muscle mass in 79% of trials (27/34), muscle strength in 82.8% (29/35), and physical performance in 92.8% (26/28). However, an additional benefit from nutritional supplementation was observed in only 23.5% (8/34) of muscle mass studies, 22.8% (8/35) of strength studies, and 14.3% (4/28) of performance studies. The authors noted high heterogeneity across exercise and supplement protocols, and noted studies were mainly performed in well-nourished subjects.
Beaudart C, Dawson A, Shaw SC, et al. Osteoporos Int, 2017. PMID 28251287
2017 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 26 RCTs (n = 2652) examined the effect of isoflavone therapies on bone mineral density (BMD) loss in peri- and postmenopausal women. Isoflavone treatment was associated with a significantly higher weighted mean difference (WMD) of BMD change compared with control at the lumbar spine (0.01, 95% CI: 0.01, 0.02; P < 0.00001) and femoral neck (18 RCTs, n = 1604; WMD 0.01, 95% CI: 0.00, 0.02; P < 0.01). In studies providing isoflavones as aglycones, the effect increased at the spine (5 RCTs, n = 682; WMD 0.04, 95% CI: 0.02, 0.05; P < 0.00001) and femoral neck (4 RCTs, n = 524; WMD 0.03, 95% CI: 0.00, 0.06; P < 0.05). The protective effect disappeared when only formulations containing predominantly isoflavone glycosides were analyzed.
Lambert MNT, Hu LM, Jeppesen PB Am J Clin Nutr, 2017. PMID 28768649
2017 / Systematic review of randomized crossover trials
A systematic review evaluated 12 randomized crossover controlled trials investigating food-based nitrate supplementation in older adults. Four trials reported enhanced physiological endurance measured by time to exhaustion. Cardiovascular outcomes were mixed, with six studies noting improved blood pressure or flow while six showed no effect, and studies examining metabolic health demonstrated no clear benefits.
Stanaway L, Rutherfurd-Markwick K, Page R, et al. Nutrients, 2017. PMID 29077028
2017 / Meta-analysis and pooled individual participant data analysis of RCTs
Researchers conducted a meta-analysis of eight trials (n=557) and a pooled individual participant data analysis of six randomized controlled trials to assess the effect of protein or amino acid supplementation versus placebo in older adults. The meta-analysis found no significant effects on lean body mass (mean difference: 0.014 kg; 95% CI: -0.152, 0.18), leg press strength (MD: 2.26 kg; 95% CI: -0.56, 5.08), leg extension strength (MD: 0.75 kg; 95% CI: -1.96, 3.47), or handgrip strength (MD: -0.002 kg; 95% CI: -0.182, 0.179). Similarly, pooled analyses showed no significant differences for lean body mass (p=0.78) or strength outcomes (all p≥0.16). The authors conclude there is no evidence that supplementation without exercise or nutritional interventions increases muscle mass or strength in predominantly healthy elderly people.
Tieland M, Franssen R, Dullemeijer C, et al. J Nutr Health Aging, 2017. PMID 29083440
2017 / Systematic review and network meta-analysis of RCTs
A systematic review and network meta-analysis evaluated fall-prevention interventions in adults aged 65 and older. In the network meta-analysis (54 RCTs, 41,596 participants), several interventions were associated with reductions in injurious falls versus usual care: exercise alone (OR 0.51; 95% CI, 0.33 to 0.79), exercise plus vision assessment/treatment (OR 0.17; 95% CI, 0.07 to 0.38), exercise plus vision and environmental modifications (OR 0.30; 95% CI, 0.13 to 0.70), and a combined strategy of clinic-level quality improvement, multifactorial assessment/treatment, calcium, and vitamin D supplementation (OR 0.12; 95% CI, 0.03 to 0.55). Pairwise meta-analysis of 2 RCTs (516 participants) showed no significant association with fall-related hospitalizations (OR 0.78; 95% CI, 0.33 to 1.81).
Tricco AC, Thomas SM, Veroniki AA, et al. JAMA, 2017. PMID 29114830
2017 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 22 randomized controlled trials evaluated the effects of creatine supplementation during resistance training (2-3 days/week for 7-52 weeks) in 721 older adults. Creatine supplementation resulted in significantly greater increases in lean tissue mass (mean difference = 1.37 kg [95% CI = 0.97-1.76]; p < 0.00001), chest press strength (SMD = 0.35 [0.16-0.53]; p = 0.0002), and leg press strength (SMD = 0.24 [0.05-0.43]; p = 0.01). The authors noted that potential mechanisms by which creatine exerts these positive effects have yet to be evaluated extensively.
Chilibeck PD, Kaviani M, Candow DG, et al. Open Access J Sports Med, 2017. PMID 29138605
2017 / Systematic review and meta-analysis of observational studies
Researchers meta-analyzed 22 observational studies (17 cross-sectional, 5 longitudinal) examining 25-hydroxyvitamin D concentrations and walking speed. Usual walking speed was slower compared with normal vitamin D (>75 nmol/L) by -0.18 m/s for severe deficiency (≤25 nmol/L), -0.08 m/s for deficiency (≤50 nmol/L), and -0.12 m/s for insufficiency (≤75 nmol/L). Slow usual walking speed was positively linked to severe deficiency (OR=2.17 [95% CI: 1.52-3.10]), deficiency (OR=1.38 [95% CI: 1.01-1.89]), and insufficiency (OR=1.38 [95% CI: 1.04-1.83]). Fast walking speed and Timed Up and Go tests also showed poorer performance with lower vitamin D status.
Shows an association, not proof of cause and effect.
Annweiler C, Henni S, Walrand S, et al. Maturitas, 2017. PMID 29150169
2016 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis evaluated the effects of soy isoflavones on vaginal atrophy symptoms and signs in menopausal women across 17 trials (9 included in quantitative analysis). Soy isoflavones significantly improved vaginal dryness compared to control (difference in means -0.204, 95% CI: -0.28 to -0.126, p < 0.001; I2 = 0.00%). However, change in maturation value was not statistically significant (standardised difference in means 0.072, 95% CI: -0.42 to 0.57, p = 0.777; I2 = 85.15%). The authors note that beneficial effects remain uncertain due to possible publication bias or vast heterogeneity among studies.
Ghazanfarpour M, Sadeghi R, Roudsari RL J Obstet Gynaecol, 2016. PMID 26440219
2016 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis evaluated 20 randomized controlled trials investigating dietary protein levels during energy restriction in adults older than 50 years. Researchers assessed diets providing under versus at least 25% of energy from protein, or 1.0 g/kg/d. Participants assigned to higher protein diets preserved greater lean mass and lost more fat mass while undergoing weight reduction.
Kim JE, O'Connor LE, Sands LP, et al. Nutr Rev, 2016. PMID 26883880
2016 / Dose-response meta-analysis of cohort studies
A systematic review and meta-analysis of 230 cohort studies evaluated the dose-response relationship between BMI and all-cause mortality. For each 5-unit increase in BMI, the summary relative risk for all-cause mortality was 1.18 (95% CI 1.15 to 1.21) in never smokers, 1.21 (1.18 to 1.25) in healthy never smokers, 1.27 (1.21 to 1.33) in healthy never smokers excluding early follow-up, and 1.05 (1.04 to 1.07) across all participants. A J-shaped dose-response relation appeared in never smokers (Pnon-linearity <0.001), with the lowest mortality risk at BMI 23-24 in never smokers, 22-23 in healthy never smokers, and 20-22 in studies with >=20 years of follow-up. A U-shaped curve emerged in analyses of all participants, smokers, studies with <5 or <10 years of follow-up, or moderate quality scores, which authors noted could be biased by residual confounding from preclinical disease.
Shows an association, not proof of cause and effect.
Aune D, Sen A, Prasad M, et al. BMJ, 2016. PMID 27146380
2016 / Pooled analysis of 3 prospective cohorts
Data from 3 prospective cohorts of older adults (n = 2,926) were pooled using random-effects models to assess the dose-response link between fruit and vegetable (FV) consumption and incident frailty over a mean 2.5-year follow-up (300 cases). Compared to no consumption, pooled ORs (95% CIs) for 1, 2, or ≥3 portions/d of fruit were 0.59 (0.27, 0.90), 0.58 (0.29, 0.86), and 0.48 (0.20, 0.75; P-trend = 0.04); for vegetables, ORs were 0.69 (0.42, 0.97), 0.56 (0.35, 0.77), and 0.52 (0.13, 0.92; P-trend < 0.01). For combined FVs, pooled ORs were 0.41, 0.47, 0.36, and 0.31 (P-trend < 0.01) for 2, 3, 4, or ≥5 portions/d versus ≤1 portion/d. The strongest association was observed with 3 portions of fruit/d and 2 portions of vegetables/d.
Shows an association, not proof of cause and effect.
García-Esquinas E, Rahi B, Peres K, et al. Am J Clin Nutr, 2016. PMID 27194305
2016 / Individual-participant-data meta-analysis of prospective cohorts
An individual-participant data meta-analysis examined 3,951,455 never-smokers without chronic diseases across 189 prospective studies, recording 385,879 deaths over a median 13.7 years of follow-up. All-cause mortality was lowest at BMI 20.0 to <25.0 kg/m2 and rose throughout the overweight and obesity categories, reaching a hazard ratio of 2.76 (95% CI 2.60-2.92) for BMI 40.0 to <60.0 kg/m2. Each 5 kg/m2 increment above 25 kg/m2 linked to higher mortality across all four continents.
Shows an association, not proof of cause and effect.
Global BMI Mortality Collaboration None, Di Angelantonio E, Bhupathiraju ShN, et al. Lancet, 2016. PMID 27423262
2016 / Systematic review and meta-analysis
A meta-analysis evaluated the connection between pesticide exposure and Alzheimer's disease across seven studies. Overall pesticide exposure was positively associated with Alzheimer's disease (OR = 1.34; 95% CI = 1.08, 1.67; n = 7), with summary odds ratios of 1.14 (95% CI = 0.94, 1.38; n = 7) for crude models and 1.37 (95% CI = 1.09, 1.71; n = 5) for adjusted models. Sensitivity analyses did not materially alter results, while higher-quality studies tended to report significant associations.
Yan D, Zhang Y, Liu L, et al. Sci Rep, 2016. PMID 27581992
2016 / Systematic review and meta-analysis of controlled trials
A systematic review identified 15 controlled trials comprising 917 older adults (mean age 77.4 years) evaluating resistance exercise training with or without protein or essential amino acid supplementation. Overall, protein supplementation did not significantly augment resistance training effects on muscle strength, muscle size, functional ability, or body composition, aside from exceptions in muscle strength in 3 studies and body composition in 2 studies. Meta-analyses were limited and inconclusive due to methodological differences between studies.
Thomas DK, Quinn MA, Saunders DH, et al. J Am Med Dir Assoc, 2016. PMID 27670605
2015 / Meta-analysis of 10 placebo-controlled RCTs
A meta-analysis evaluated 10 placebo-controlled randomized controlled trials (1,024 participants, duration 6 weeks to 30 months) on soy isoflavone (SIF) supplementation in postmenopausal women. SIF supplementation resulted in a statistically significant overall standardized mean difference (SMD) in summary cognitive function test scores of 0.08 (95% CI, 0.02-0.15; P = 0.014) and in visual memory of 0.10 (95% CI, 0.02-0.18; P = 0.016). Significant SMDs were observed in subgroups for non-US countries (0.12), mean age younger than 60 years (0.16), and treatment duration under 12 months (0.15).
Cheng PF, Chen JJ, Zhou XY, et al. Menopause, 2015. PMID 25003621
2015 / Meta-analysis and systematic review of RCTs
A meta-analysis of 15 randomized controlled trials examined the efficacy of oral phytoestrogens for menopausal symptoms in women across interventions lasting 3 to 12 months. Phytoestrogens significantly reduced daily hot flush frequency compared to placebo across 10 studies (pooled mean difference = 0.89, p < 0.005). However, meta-analysis of seven studies reporting Kupperman index data found no significant difference compared to placebo (pooled mean difference = 6.44, p = 0.110). Analysis of five studies showed no significant difference in side effects between groups (p = 0.175).
Chen MN, Lin CC, Liu CF Climacteric, 2015. PMID 25263312
2015 / Model-based meta-analysis
A model-based meta-analysis analyzed 16 studies covering about 1,710 subjects to model the time course of hot flash reduction with soy isoflavones versus placebo. The maximal reduction by soy isoflavones after eliminating the placebo effect was 25.2%, representing 57% of the maximum effect seen with estradiol (44.9%). Soy isoflavones required 13.4 weeks to reach half of their maximal effect, compared to 3.09 weeks for estradiol, and would require at least 48 weeks to achieve 80% of their maximum effect. The authors concluded that soy isoflavones exhibit slight and slow effects in reducing hot flashes compared with estradiol.
Li L, Lv Y, Xu L, et al. Br J Clin Pharmacol, 2015. PMID 25316502
2015 / Systematic review and meta-analysis
A systematic review and meta-analysis assessed the short-term effects of music therapy on cognitive function in older adults across five studies. Although individual studies suggested active music therapy improved Mini-Mental State Examination scores, combined meta-analysis showed no statistically significant improvement overall (pooled mean difference 0.73, 95% CI -0.07 to 1.54, P = .07) or for active music therapy specifically (pooled mean difference 0.74, 95% CI -0.08 to 1.56, P = .08). The authors concluded that short-term music therapy does not improve cognitive function in older people and noted the need for higher-quality, long-term studies.
Li HC, Wang HH, Chou FH, et al. J Am Med Dir Assoc, 2015. PMID 25458447
2015 / Pooled analysis of prospective cohorts
Data from 6 prospective cohort studies totaling 661,137 men and women were pooled to evaluate the dose-response relationship between leisure time physical activity and mortality over a median follow-up of 14.2 years. Compared with no activity, mortality risk was lower among those performing less than the recommended minimum of 7.5 MET-hours/week (HR 0.80), 1 to 2 times the minimum (HR 0.69), and 2 to 3 times the minimum (HR 0.63). An upper threshold of benefit was seen at 3 to 5 times the recommended minimum (HR 0.61), with no evidence of harm observed at 10 or more times the minimum (HR 0.69). Similar dose-response associations were found for cardiovascular disease and cancer mortality.
Shows an association, not proof of cause and effect.
Arem H, Moore SC, Patel A, et al. JAMA Intern Med, 2015. PMID 25844730
2015 / Meta-analysis of prospective longitudinal studies
A meta-analysis of nine longitudinal studies comprising 20,326 participants aged 65 years or older was conducted to assess the association between physical activity and Alzheimer's disease risk. The fixed effects risk ratio was 0.61 (95% CI 0.52-0.73), indicating a statistically significant overall reduction in risk of Alzheimer's disease in physically active older adults compared to non-active counterparts.
Shows an association, not proof of cause and effect.
Beckett MW, Ardern CI, Rotondi MA BMC Geriatr, 2015. PMID 25887627
2015 / Systematic review and meta-analysis of prospective cohort studies
In a systematic review of 23 cohort studies, 20 out of 51 evaluated blood-borne indicators were associated with mortality risk. Meta-analyses identified associations between mortality and C-reactive protein (all-cause HR 1.42, p<0.001; cancer HR 1.62, p<0.009; CVD HR 1.31, p=0.033), NT-proBNP, and white blood cell count. Several additional markers showed potential utility, whereas others had equivocal support or lacked fatal risk connections.
Shows an association, not proof of cause and effect.
Barron E, Lara J, White M, et al. PLoS One, 2015. PMID 26039142
2015 / Systematic review and meta-analysis
A systematic review examined RCTs and cohort studies on calcium intake and fractures in people over 50. Most cohort studies found no association between fractures and dietary calcium, milk, or dairy intake. In 26 RCTs, calcium supplements slightly reduced total fracture (20 studies, n=58,573; RR 0.89, 95% CI 0.81 to 0.96) and vertebral fracture (12 studies, n=48,967; RR 0.86, 0.74 to 1.00), but not hip or forearm fracture. In RCTs with the lowest risk of bias (4 studies, n=44,505), calcium showed no effect at any site, and funnel plot analysis suggested publication bias.
Bolland MJ, Leung W, Tai V, et al. BMJ, 2015. PMID 26420387
2014 / Systematic review and meta-analysis of randomized trials
Across 56 randomized trials with 95,286 participants, supplemental vitamin D decreased all-cause mortality (RR 0.97; 95% CI 0.94 to 0.99; P = 0.02). When examined by specific compound, only cholecalciferol yielded a significant reduction in mortality (RR 0.94; 95% CI 0.91 to 0.98; 38 trials), whereas ergocalciferol and active forms showed no significant mortality benefit. Vitamin D3 also lowered cancer mortality (RR 0.88; 95% CI 0.78 to 0.98), but combined use with calcium raised nephrolithiasis risk.
Bjelakovic G, Gluud LL, Nikolova D, et al. Cochrane Database Syst Rev, 2014. PMID 24414552